Association Of Lpp And Tagap Polymorphisms With Celiac Disease Risk: A Meta-Analysis

Shi-Qi Huang,Na Zhang,Zi-Xing Zhou,Chui-Can Huang,Cheng-Li Zeng,Di Xiao,Cong-Cong Guo,Ya-Jing Han,Xiao-Hong Ye,Xing-Guang Ye,Mei-Ling Ou,Bao-Huan Zhang,Yang Liu,Eddy Y. Zeng,Guang Yang,Chun-Xia Jing

DOI: https://doi.org/10.3390/ijerph14020171

IF: 4.614

2017-01-01

International Journal of Environmental Research and Public Health

Abstract:Background: Lipoma preferred partner (LPP) and T-cell activation Rho GTPase activating protein (TAGAP) polymorphisms might influence the susceptibility to celiac disease. Therefore, we performed a meta-analysis by identifying relevant studies to estimate the risks of these polymorphisms on celiac disease. Methods: The PubMed, Web of Science and Embase databases were searched (up to October 2016) for LPP rs1464510 and TAGAP rs1738074 polymorphisms. Results: This meta-analysis included the same 7 studies for LPP rs1464510 and TAGAP rs1738074. The minor risk A allele at both rs1464510 and rs1738074 carried risks (odds ratios) of 1.26 (95% CI: 1.22-1.30) and 1.17 (95% CI: 1.14-1.21), respectively, which contributed to increased risks in all celiac disease patients by 10.72% and 6.59%, respectively. The estimated lambdas were 0.512 and 0.496, respectively, suggesting that a co-dominant model would be suitable for both gene effects. Conclusions: This meta-analysis provides robust estimates that polymorphisms in LPP and TAGAP genes are potential risk factors for celiac disease in European and American. Prospective studies and more genome-wide association studies (GWAS) are needed to confirm these findings, and some corresponding molecular biology experiments should be carried out to clarify the pathogenic mechanisms of celiac disease.